NYU Hepatology Associates
New York, New York, United States
Medical center in New York City, New York
530 1st Ave. #4j, New York, NY 10016
About NYU Hepatology Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Sciences Ireland UC
2
Calliditas Therapeutics AB
1
Gilead Sciences
1
Clinical Trials at NYU Hepatology Associates
During the past decade, NYU Hepatology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
2010-10-01
2013-09-01
Completed
245
Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.
2017-06-26
2019-04-11
Completed
111
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
2018-02-13
2020-08-13
Completed
232
A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection
2019-08-01
2022-04-26
Completed
471
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NYU Hepatology Associates
According to Clinical.Site data, the most researched conditions in "NYU Hepatology Associates" are
"Hepatitis B" (1 trials), "Hepatitis B, Chronic" (1 trials), "Hepatitis C, Chronic" (1 trials) and "Primary Biliary Cirrhosis" (1 trials). Many other conditions were trialed in "NYU Hepatology Associates" in a lesser frequency.
Clinical Trials Intervention Types at NYU Hepatology Associates
Most popular intervention types in "NYU Hepatology Associates" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "JNJ-56136379" (2 trials), "Copegus®" (1 trials), "GKT137831" (1 trials), "GS-9451" (1 trials) and "GS-9451 placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NYU Hepatology Associates
The vast majority of trials in "NYU Hepatology Associates" are
4 trials for "All" genders.
Clinical Trials Status at NYU Hepatology Associates
Currently, there are NaN active trials in "NYU Hepatology Associates".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in NYU Hepatology Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NYU Hepatology Associates, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".